Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFN
2526
DELISTED
Infinera Corporation Common Stock
INFN
| $6.72M | ﹤0.01% |
2,309,078
+538,389
| +30% | +$2.02M |
|
|
JKS
2527
CALL
JinkoSolar
JKS
$877M
| $6.72M | ﹤0.01% |
309,700
+137,300
| +80% | +$2.77M |
|
|
KNL
2528
DELISTED
Knoll, Inc.
KNL
| $6.71M | ﹤0.01% |
292,168
+7,205
| +3% | +$149K |
|
2529
CALL
Vipshop
VIPS
$6.81B
| $6.71M | ﹤0.01% |
777,700
-1,564,300
| -67% | -$12.6M |
|
2530
CALL
Exelixis
EXEL
$12.7B
| $6.71M | ﹤0.01% |
313,800
-101,400
| -24% | -$2.13M |
|
|
CMA
2531
CALL
DELISTED
Comerica
CMA
| $6.71M | ﹤0.01% |
92,300
+1,200
| +1% | +$89.2K |
|
2532
Bank of Hawaii
BOH
$3.17B
| $6.7M | ﹤0.01% |
80,830
-223,933
| -73% | -$18M |
|
2533
CALL
Franco-Nevada
FNV
$45.2B
| $6.7M | ﹤0.01% |
78,900
-52,000
| -40% | -$3.93M |
|
2534
CALL
ProShares UltraPro Short QQQ
SQQQ
$1.68B
| $6.68M | ﹤0.01% |
304
+122
| +67% | +$2.88M |
|
2535
RB Global
RBA
$15.6B
| $6.68M | ﹤0.01% |
201,012
-110,010
| -35% | -$3.76M |
|
|
AXON
2536
CALL
Axon Enterprise
AXON
$49.8B
| $6.68M | ﹤0.01% |
104,000
-9,200
| -8% | -$600K |
|
2537
PUT
Zimmer Biomet
ZBH
$19.2B
| $6.68M | ﹤0.01% |
58,401
+36,050
| +161% | +$4.22M |
|
2538
CALL
Cooper Companies
COO
$14.9B
| $6.67M | ﹤0.01% |
79,200
+33,600
| +74% | +$2.53M |
|
2539
GSK
GSK
$99.2B
| $6.67M | ﹤0.01% |
133,288
-289,426
| -68% | -$14.5M |
|
2540
Hancock Whitney
HWC
$6.4B
| $6.67M | ﹤0.01% |
166,429
-24,762
| -13% | -$1.02M |
|
2541
PUT
Steel Dynamics
STLD
$36.7B
| $6.66M | ﹤0.01% |
220,400
+140,100
| +174% | +$4.29M |
|
2542
PUT
AstraZeneca
AZN
$243B
| $6.65M | ﹤0.01% |
80,600
+3,150
| +4% | +$247K |
|
2543
Guardant Health
GH
$21.1B
| $6.65M | ﹤0.01% |
77,074
-15,348
| -17% | -$1.17M |
|
2544
Choice Hotels
CHH
$4.7B
| $6.65M | ﹤0.01% |
76,392
+7,762
| +11% | +$648K |
|
2545
Sonoco
SON
$5.76B
| $6.64M | ﹤0.01% |
101,688
-105,377
| -51% | -$6.66M |
|
2546
iShares MSCI Europe Financials ETF
EUFN
$4.31B
| $6.64M | ﹤0.01% |
365,851
-354,668
| -49% | -$6.64M |
|
2547
CALL
Canadian Natural Resources
CNQ
$98.9B
| $6.63M | ﹤0.01% |
502,128
+12,252
| +3% | +$168K |
|
|
2548
PUT
GSK
GSK
$99.2B
| $6.62M | ﹤0.01% |
132,320
-22,720
| -15% | -$1.14M |
|
|
CCMP
2549
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $6.61M | ﹤0.01% |
60,056
-21,577
| -26% | -$2.44M |
|
2550
Malibu Boats
MBUU
$576M
| $6.61M | ﹤0.01% |
170,111
+155,516
| +1,066% | +$6.18M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.